[1]
2025. Discordance of HER2 between primary tumors and lymph node metastatic lesions in invasive breast cancer. Universa Medicina. 44, 1 (Feb. 2025), 43–49. DOI:https://doi.org/10.18051/UnivMed.2025.v44.43-49.